肥胖与心房颤动综述：探索其中的矛盾
Review Of Obesity And Atrial Fibrillation: Exploring The Paradox.
作者信息
Cambeiro González, Cristina María, Mañero Rodríguez, Roubin Raposeiras, Assi Abu, Juanatey González, Ramón José
机构信息
Servicio de Cardiología y Unidad Coronaria, Hospital Clínico Universitario de Santiago de Compostela, Spain.
出版信息
J Atr Fibrillation. 2015 Aug 31;8(2):1259. doi: 10.4022/jafib.1259. eCollection 2015 Aug-Sep.
Abstract
There is a well established association between obesity and atrial fibrillation (AF). Nevertheless, the effects of obesity in the outcomes of patients with AF has not been investigated since a few years before. In this regard, several studies have demonstrated a better clinical prognosis of AF in overweight and obese populations. In the present manuscrit, we aimed to explore the main articles in which the "obesity paradox in AF" was found.
摘要
肥胖与心房颤动（AF）之间存在着已被充分证实的关联。然而，肥胖对房颤患者预后的影响在数年前就未曾被研究过。在这方面，多项研究表明超重和肥胖人群中房颤的临床预后较好。在本手稿中，我们旨在探讨发现“房颤中的肥胖悖论”的主要文章。
相似文献
1
Review Of Obesity And Atrial Fibrillation: Exploring The Paradox.
J Atr Fibrillation. 2015 Aug 31;8(2):1259. doi: 10.4022/jafib.1259. eCollection 2015 Aug-Sep.
2
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry.
J Cardiovasc Electrophysiol. 2018 Apr;29(4):566-572. doi: 10.1111/jce.13428. Epub 2018 Feb 1.
3
Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.
J Am Coll Cardiol. 2017 Oct 17;70(16):2022-2035. doi: 10.1016/j.jacc.2017.09.002.
4
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials.
Stroke. 2017 Apr;48(4):857-866. doi: 10.1161/STROKEAHA.116.015984. Epub 2017 Mar 6.
5
Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
Am J Med. 2010 Jul;123(7):646-51. doi: 10.1016/j.amjmed.2009.11.026.
6
Exploring The Obesity Paradox In Atrial Fibrillation. AFBAR (Atrial Fibrillation Barbanza Area) Registry Results.
J Atr Fibrillation. 2014 Feb 28;6(5):991. doi: 10.4022/jafib.991. eCollection 2014 Feb-Mar.
7
The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.
Eur Heart J. 2016 Oct 7;37(38):2869-2878. doi: 10.1093/eurheartj/ehw124. Epub 2016 Apr 12.
8
Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.
J Cardiovasc Electrophysiol. 2018 Feb;29(2):239-245. doi: 10.1111/jce.13388. Epub 2017 Dec 14.
9
[Association between weight control and recurrence of atrial fibrillation after catheter ablation in overweight and obese patients].
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Aug 24;47(8):595-601. doi: 10.3760/cma.j.issn.0253-3758.2019.08.002.
10
Obesity and risk of new-onset atrial fibrillation after cardiac surgery.
Circulation. 2005 Nov 22;112(21):3247-55. doi: 10.1161/CIRCULATIONAHA.105.553743. Epub 2005 Nov 14.
引用本文的文献
1
Association between obesity and statin use on mortality and hospital encounters in atrial fibrillation.
Int J Cardiol Heart Vasc. 2024 Jun 25;53:101450. doi: 10.1016/j.ijcha.2024.101450. eCollection 2024 Aug.
2
Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation.
Cells. 2023 Feb 16;12(4):638. doi: 10.3390/cells12040638.
3
Race, Body Mass Index, and the Risk of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.
J Am Heart Assoc. 2021 Jan 5;10(1):e018592. doi: 10.1161/JAHA.120.018592. Epub 2020 Dec 31.
4
Evaluation of risk factors and drug adherence in the occurrence of stroke in patients with atrial fibrillation.
Pharm Pract (Granada). 2020 Apr-Jun;18(2):1860. doi: 10.18549/PharmPract.2020.2.1860. Epub 2020 Jun 3.
5
Effects of L. Seeds and Juice on Liver Steatosis in an Animal Model of Diet-Induced Obesity.
Nutrients. 2020 May 4;12(5):1308. doi: 10.3390/nu12051308.
6
Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry.
Cerebrovasc Dis Extra. 2018;8(2):50-59. doi: 10.1159/000488206. Epub 2018 May 22.
本文引用的文献
1
Exploring The Obesity Paradox In Atrial Fibrillation. AFBAR (Atrial Fibrillation Barbanza Area) Registry Results.
J Atr Fibrillation. 2014 Feb 28;6(5):991. doi: 10.4022/jafib.991. eCollection 2014 Feb-Mar.
2
Obesity paradox in patients with atrial fibrillation and heart failure.
Int J Cardiol. 2014 Oct 20;176(3):1356-8. doi: 10.1016/j.ijcard.2014.07.264. Epub 2014 Aug 6.
3
Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.
JAMA. 2013 Jan 2;309(1):71-82. doi: 10.1001/jama.2012.113905.
4
Relation of body fat categories by Gallagher classification and by continuous variables to mortality in patients with coronary heart disease.
Am J Cardiol. 2013 Mar 1;111(5):657-60. doi: 10.1016/j.amjcard.2012.11.013. Epub 2012 Dec 19.
5
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.
Europace. 2012 Oct;14(10):1385-413. doi: 10.1093/europace/eus305. Epub 2012 Aug 24.
6
"Obesity paradox" in chronic obstructive pulmonary disease.
Isr Med Assoc J. 2011 Nov;13(11):672-5.
7
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
JAMA. 2012 Feb 1;307(5):491-7. doi: 10.1001/jama.2012.39. Epub 2012 Jan 17.
8
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.
Lancet. 2011 Mar 26;377(9771):1085-95. doi: 10.1016/S0140-6736(11)60105-0.
9
Obesity and outcomes among patients with established atrial fibrillation.
Am J Cardiol. 2010 Aug 1;106(3):369-73. doi: 10.1016/j.amjcard.2010.03.036.
10
Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
Am J Med. 2010 Jul;123(7):646-51. doi: 10.1016/j.amjmed.2009.11.026.
Zotero 插件